. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature. 2001 Nov 8;414(6860):212-6. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

  1. This study suggests a novel mechanism by which NSAIDs might be protective in AD, and a potentially novel and selective mechanism for lowering Ab42 production. This is important because Ab42 is thought to be a critical factor initiating Ab aggregation. -- Benjamin Wolozin

  2. The most innovative paper from 2001, which provided a novel means of
    modulating γ-secretase activity.